Alzheimer Disease: Dimebon Results, Part II

From The New York Times:

Hopes for Alzheimer’s Drug Are Dashed
By ANDREW POLLACK
Published: March 4, 2010

"The drug, called Dimebon, failed in its first late-stage clinical trial, dealing a blow to patients with Alzheimer’s and the companies developing the treatment, Medivation and Pfizer."

Read the full article